07/23/2014 - 1:02pm

The Food and Drug Administration on Wednesday announced approval for Zydelig (idelalisib) to treat patients with chronic lymphocytic leukemia, relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small lymphocytic lymphoma.

07/23/2014 - 9:43am

Mylan on Wednesday announced that U.S. District Court for the district of New Jersey granted a temporary restraining order against Apotex Inc. and Apotex Corp. relating to Paroxetine CR.

07/22/2014 - 1:41pm

The Food and Drug Administration has granted tentative approval to Teva Pharmaceutical for abacavir sulfate and lamivudine tablets, according to agency records.

07/21/2014 - 4:01pm

Illinois Gov. Pat Quinn signed a bill Monday that opens up medical marijuana to treat symptoms of epilepsy in adults and children.

07/21/2014 - 2:44pm

The Food and Drug Administration’s Center for Drug Evaluation and Research is providing an update to key leadership positions within the Office of Generic Drugs, the agency announced.

07/21/2014 - 12:33pm

AbbVie has finalized a deal for Dublin-based specialty pharmaceuticals company Shire for $54.7 billion.

07/18/2014 - 10:35am

The Food and Drug Administration on Thursday announced the approval of Ruconest, a recombinant C1-Esterase inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.

07/18/2014 - 5:52am

FedEx on Thursday was indicted as a co-conspirator for illegally distributing pharmaceuticals sourced from a pair of rogue online pharmacies.

 

07/17/2014 - 12:27pm

There is “something brewing in Congress” these days, NACDS president and CEO Steve Anderson wrote in a July 16 newsletter to NACDS chain members.